The analysis of approximately 300 biopsies revealed that leptin is overexpressed in breast cancer, whereas it is absent or expressed at very low levels in normal epithelium or benign tumours (Ishikawa et al, 2004; Garofalo et al, 2006). This evidence concerns the gene LEP and breast carcinoma.